Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s disease

2 Apr 2018

Abstract excerpt

// Marcia Cristina T. dos Santos 1 , Miguel Arturo Barreto-Sanz 2 , Bruna Renata S. Correia 3 , Rosie Bell 4 , Catherine Widnall 5 , Luis Tosar Perez 6 , Caroline Berteau 5 , Claudia Schulte 7 , Dieter Scheller 8 , Daniela Berg 7, 9 , Walter Maetzler 7, 9 , Pedro A.F. Galante 3 and Andre Nogueira da Costa 1 1 Experimental Medicine and Diagnostics, Global Exploratory Development, UCB Biopharma SPRL,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Neurological disorders and treatments
Share to Parkinson's Disease Mechanisms and Treatments
Share to RNA regulation and disease

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29707120
DOI: 10.18632/oncotarget.24736

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

miRNA-based signatures in cerebrospinal fluid as potential diagnostic tools for early stage Parkinson’s diseasePMID 29707120Read ↗

Circulating Brain‐Enriched MicroRNAs for Detection and Discrimination of Idiopathic and Genetic Parkinson's DiseaseSemantic proximity Read ↗

Proteome profiling of cerebrospinal fluid reveals biomarker candidates for Parkinson’s diseaseSemantic proximity Read ↗

Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomicsSemantic proximity Read ↗

Validation of Differentially Expressed Brain-Enriched microRNAs in the Plasma of Parkinson’s Disease PatientsSemantic proximity Read ↗

MicroRNAs in Parkinson’s disease: A systematic review and diagnostic accuracy meta-analysisSemantic proximity Read ↗

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s diseaseSemantic proximity Read ↗

Serum Exosomal miRNAs as Biomarkers of Early Diagnosis and Progression in Parkinson's DiseaseSemantic proximity Read ↗

MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive reviewSemantic proximity Read ↗

Cerebrospinal fluid biomarker for Parkinson's disease: An overviewSemantic proximity Read ↗

Plasma miRNA Biomarker Signatures in Parkinsonian SyndromesSemantic proximity Read ↗

Changes in the cerebrospinal fluid proteome precede and stratify the course of Parkinson’s DiseaseSemantic proximity Read ↗

Dysregulated miRNAs as Biomarkers and Therapeutical Targets in Neurodegenerative DiseasesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.